Safety and tolerability of nintedanib in patients with systemic sclerosis-associated interstitial lung disease: data from the SENSCIS trial
Seibold, James R, Maher, Toby M, Highland, Kristin B, Assassi, Shervin, Azuma, Arata, Hummers, Laura Kathleen, Costabel, Ulrich, von Wangenheim, Ute, Kohlbrenner, Veronika, Gahlemann, Martina, Alves,Journal:
Annals of the Rheumatic Diseases
DOI:
10.1136/annrheumdis-2020-217331
Date:
August, 2020
Fichier:
PDF, 1.83 MB
2020
File converter
Plus de résultats de recherche
More benefits 
